Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|March 8, 2022
Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus InfectionLung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, et al.
Journal of Gastroenterology and Hepatology|April 3, 2022
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis BRex Wan-Hin Hui, Keith Wan-Hang Chiu, Lung Yi Mak, et al.
JHEP Reports : Innovation in Hepatology|September 2, 2025
Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatmentRex Wan-Hin Hui, Danny Ka-Ho Wong, Xueying Lyu, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2023
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assaysDanny Ka-Ho Wong, Takako Inoue, Lung-Yi Mak, et al.
Hepatology International|June 21, 2021
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infectionLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
JHEP Reports : Innovation in Hepatology|August 6, 2026
HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long term nucleos(t)ide analogueLung-Yi Mak, Mark Anderson, Rex Wan-Hin Hui, et al.
Clinical and Molecular Hepatology|December 26, 2024
Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parametersLung-Yi Mak, Mark Anderson, Michael Stec, et al.
Clinical and Molecular Hepatology|May 11, 2022
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipientsKa Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, et al.
JHEP Reports : Innovation in Hepatology|January 8, 2026
Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysisLu Li, Xianhua Mao, Chi Ho Lee, et al.
International Journal of Obesity (2005)|July 17, 2026
Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD)Karen Cheuk-Ying Ho, Rex Wan-Hin Hui, Trevor Kwan-Hung Wu, et al.
Pageof 6